🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
There will be 2 phases in this study. Patients will either be enrolled to t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2006-09
Trial ID
NCT00402116
Treatments Being Tested
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638
This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part. ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT03283046
Treatments Being Tested
This is a single center, open-label, nonrandomized, phase 1b study of TRC10...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2015-11-02
Trial ID
NCT02429843
Treatments Being Tested
The aim of this study is to determine the maximal tolerated dose level of l...
Status
Completed
Location
Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie
Start Date
2008-10
Trial ID
NCT00738829
Treatments Being Tested
The purpose of this study is to test the safety of combined use of the stud...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2018-08-23
Trial ID
NCT03581942
Treatments Being Tested
This Phase I, open-label, dose-finding, multicenter study is designed to de...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-13
Trial ID
NCT02215096
Treatments Being Tested
This is a single arm, open-label, multi-center, pilot studies (Investigator...
Status
Recruiting
Location
First Affiliated Hospital of Fujian Medical University
Start Date
2024-09-01
Trial ID
NCT06568328
Treatments Being Tested